Q3 2024 Holdings
Filed 2024-11-13 | 62 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $196.8M | 1,550,280 | 15.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $123.5M | 2,793,987 | 9.8% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $86.5M | 726,329 | 6.9% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $63.1M | 809,406 | 5.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $55.4M | 1,749,455 | 4.4% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $51.7M | 3,518,684 | 4.1% |
| BioAge Labs Inc(BIOA) | COM | 09077V100 | $47.9M | 2,304,901 | 3.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $47.2M | 714,176 | 3.7% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $40.9M | 1,995,594 | 3.2% |
| Arrivent BioPharma Inc(AVBP) | COM | 04272N102 | $39.9M | 1,696,752 | 3.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $34.1M | 379,527 | 2.7% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $29.6M | 586,344 | 2.3% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $28.9M | 2,194,278 | 2.3% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $27.7M | 772,070 | 2.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $24.5M | 2,265,230 | 1.9% |
| Savara Inc(SVRA) | COM | 805111101 | $24.0M | 5,662,550 | 1.9% |
| Novartis AG(NVSN)Put | SPONSORED ADR | 66987V109 | $23.0M | 200,000 | 1.8% |
| Inozyme Pharma Inc | COM | 45790W108 | $22.4M | 4,280,308 | 1.8% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $21.0M | 188,562 | 1.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $20.9M | 286,307 | 1.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $15.1M | 786,999 | 1.2% |
| Soleno Therapeutics Inc(SLNO)Put | COM | 834203309 | $15.1M | 300,000 | 1.2% |
| Rhythm Pharmaceuticals(RYTM) | COM | 76243J105 | $14.5M | 276,678 | 1.2% |
| Axsome Therapeutics Inc(AXSM)Put | COM | 05464T104 | $13.5M | 150,000 | 1.1% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $13.4M | 202,898 | 1.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $11.4M | 135,819 | 0.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $11.1M | 600,302 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.3M | 384,767 | 0.8% |
| Immunome Inc(IMNM) | COM | 45257U108 | $9.9M | 676,766 | 0.8% |
| Guardant Health Inc(GH) | COM | 40131M109 | $9.3M | 406,645 | 0.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $9.2M | 203,271 | 0.7% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $8.4M | 536,068 | 0.7% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $8.4M | 358,644 | 0.7% |
| Aerovate Therapeutics Inc | COM | 008064107 | $7.9M | 3,758,686 | 0.6% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $7.9M | 181,476 | 0.6% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $7.7M | 4,386,177 | 0.6% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $7.5M | 164,770 | 0.6% |
| Cabaletta Bio Inc(CABA) | COM | 12674W109 | $7.2M | 1,533,883 | 0.6% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $7.2M | 1,514,032 | 0.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $5.8M | 296,884 | 0.5% |
| Phibro Animal Health Corp(PAHC) | CL A COM | 71742Q106 | $5.4M | 238,184 | 0.4% |
| Illumina Inc(ILMN) | COM | 452327109 | $5.3M | 40,611 | 0.4% |
| Erasca Inc(ERAS) | COM | 29479A108 | $5.0M | 1,842,668 | 0.4% |
| Immatics N.v(IMTX) | SHS | N44445109 | $4.4M | 386,100 | 0.3% |
| Inari Med Inc(NARIUSD) | COM | 45332Y109 | $3.7M | 90,327 | 0.3% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $3.7M | 15,191 | 0.3% |
| Nextcure Inc | COM | 65343E108 | $3.7M | 2,671,856 | 0.3% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $3.6M | 5,770 | 0.3% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $2.6M | 37,637 | 0.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $2.0M | 41,352 | 0.2% |